When we performed flow cytometric analyses for CD19, CD5, and GFP expression, we observed a moderate reduction in CLL in the lymph nodes (Fig. 1l) but not in the spleen (Fig. 1m). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.